Fisher Asset Management
EVH icon

Fisher Asset Management’s Evolent Health EVH Stock Holding History

Fisher Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-170
Closed -$4.63K – 1022
2023
Q3 		$4.63K Hold
170
– – ﹤0.01% 1120
2023
Q2 		$5.15K Hold
170
– – ﹤0.01% 1120
2023
Q1 		$5.52K Buy
+170
New +$5.38K ﹤0.01% 1072

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Fisher Asset Management's EVH Position: Q4 2023 in Review

Fisher Asset Management sold out of Evolent Health (EVH) in Q4 2023, closing a stake of 170 shares — an estimated $4.63K sold.

Fisher Asset Management first reported a position in EVH in Q1 2023 and held it in 3 quarters. The position peaked at $5.52K in Q1 2023. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

  • Fisher Asset Management reported no remaining Evolent Health position as of Q4 2023 after selling out during the quarter.
  • Fisher Asset Management sold 170 Evolent Health shares in Q4 2023, an estimated $4.63K.
  • Fisher Asset Management first reported a position in Evolent Health in Q1 2023 and held it in 3 quarters.
  • Fisher Asset Management's Evolent Health position peaked at $5.52K in Q1 2023.
  • 234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.